Science & Enterprise subscription

Follow us on Twitter

  • Research done at Massachusetts Institute of Technology in 2018 led to creation of 32 new start-up enterprises as w… https://t.co/XDS3u9zDEX
    about 16 hours ago
  • New post on Science and Enterprise: MIT Spins-Off 32 Start-Ups in 2018 https://t.co/MwJpYlGhwV #Science #Business #AAASmtg
    about 16 hours ago
  • New contributed post on Science and Enterprise: https://t.co/MCiZyaoc0I Ships Are Becoming Safer With Technology
    about 19 hours ago
  • A panel of data and behavioral scientists envision great potential for blockchain in science, but show few cases o… https://t.co/Ch0yJRek4W
    about 2 days ago
  • New post on Science and Enterprise: Blockchain and Science, Not Ready for Prime Time https://t.co/mYiRQ0j8vU #Science #Business #AAASmtg
    about 2 days ago

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn
INSTAGRAM

In Case You Missed It …

(tigerlily713, Pixabay)

12 August 2018. Many of today’s cancer drugs are given with intravenous infusions to bypass digestive acids and enzymes that degrade and interfere with the active ingredients. We reported last week on a team at University of Colorado’s medical campus in Denver proposing a way to formulate cancer therapies as oral drugs. Their technique — use the components in milk that enable mothers to pass antibodies to their babies, shielded from the digestive system. NIH is funding the research with a 4-year award.

For this task, the researchers plan to harness exosomes, a topic we’ve written on a few times recently. Exosomes are tiny — 40 to 150 nanometer — lipid-membrane containers in cells that gather up and secrete cytoplasm, the gel-like material outside the cell nucleus. While originally believed to carry out waste removal and other maintenance tasks, exosomes are shown in recent years to perform useful delivery functions carrying proteins and genetic material to other cells, and drawing increased attention from a range of biological disciplines.

Here are other stories we covered last week:

*     *     *

Please share Science & Enterprise ...

Comments are closed.